| FDA: New Warning for Procrit, Epogen, Aranesp - WebMD |
|
|
WebMD The advice is different for CKD patients on dialysis and for CKD patients not on dialysis. Begin ESA treatment when the hemoglobin level is less than 10 g/dL. If the hemoglobin level approaches or reaches 11 g/dL, reduce the ESA dose or suspend ... FDA places dose limits on anemia drugs Cardiovascular Business New Dosing Guidelines for Erythropoiesis-Stimulating Agents Medscape Breaking news: FDA calls for changes in ESA dosing for patients with chronic |